科研之友
微信
新浪微博
Facebook
分享链接
摘要
Objective-To evaluate the duration of effects on movement patterns of horses after sedation with equipotent doses of xylazine hydrochloride, detomidine hydrochloride, or romifidine hydrochloride and determine whether accelerometry can be used to quantify differences among drug treatments. %26lt;br%26gt;Animals-6 healthy horses. %26lt;br%26gt;Procedures Each horse was injected IV with saline (0.9% NaCI) solution (10 mL), xylazine diluted in saline solution (0.5 mg/kg), detomidine diluted in saline solution (0.01 mg/kg), or romifidine diluted in saline solution (0.04 mg/kg) in random order. A triaxial accelerometric device was used for gait assessment 15 minutes before and 5, 15, 30, 45, 60, 75, 90, 105, and 120 minutes after each treatment. Eight variables were calculated, including speed, stride frequency, stride length, regularity, dorsoventral power, propulsive power, mediolateral power, and total power; the force of acceleration and 3 components of power were then calculated. %26lt;br%26gt;Results Significant differences were evident in stride frequency and regularity between treatments with saline solution and each alpha(2)-adrenoceptor agonist drug; in speed, dorsoventral power, propulsive power, total power, and force values between treatments with saline solution and detomidine or romifidine; and in mediolateral power between treatments with saline solution and detomidine. Stride length did not differ among treatments. %26lt;br%26gt;Conclusions and Clinical Relevance-Accelerometric evaluation of horses administered alpha(2)-adrenoceptor agonist drugs revealed more prolonged sedative effects of romifidine, compared with effects of xylazine or detomidine. Accelerometry could be useful in assessing the effects of other sedatives and analgesics. Accelerometric data may be helpful in drug selection for situations in which a horse%26apos;s balance and coordination are important. (Am J Vet Res 2013;74:828-834)
- 出版日期2013-6
